Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU research fights killer viruses’ stubborn resistance to drugs

29.06.2004


Viruses’ growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences. The EU is therefore contributing € 9 million to the “Vigilance against Viral Resistance” (VIRGIL) project, to be launched today in Lyon (France). It will start by addressing drug resistance in viral hepatitis and influenza, but will broaden its scope to other viruses. The network will be based on research and technological platforms to monitor existing, and anticipate future, drug resistance. One platform will monitor, test and improve the management of antiviral drug resistance in patients while another will show how resistance occurs and help understand patient-related (immune/genetic) factors causing viral resistance. Other platforms for drugs and pharmacology and for innovation and technology will allow anticipation of ways to rapidly overcome drug resistance. Finally, a societal impact platform will assess the network’s benefit for medicine and patients’ quality of life. VIRGIL, coordinated by Lyon’s INSERM research centre, will gather 55 key European field experts from 12 countries, including 7 partners from industry.

“The heavy use of antibiotics, particularly in hospitals, hastens mutations in bacteria which bring about drug resistance. The same happens in viruses when antiviral drugs are used extensively,” European Research Commissioner Philippe Busquin said. “VIRGIL complements a €30 million EU research investment into antimicrobial drug resistance over the past two years to address this growing problem. Through collaboration between European academic researchers, the pharmaceutical industry, clinicians and public health authorities the network will help overcome problems associated with viral drug resistance to help save lives.”

Killer diseases: on the rampage?



Viral hepatitis causes chronic liver disease, including cirrhosis and liver cancer. Although a safe and efficient vaccine does exist for hepatitis B, over 350 million people around the world are now chronically infected with this virus. For hepatitis C, no vaccine exists and over 1% of Europeans are carriers. Intensive clinical use of the few available drugs has led to rapidly emerging drug resistance for some viruses so that these drugs are no longer efficient.

Yearly epidemics of new flu strains infect 5-15% of the world population with up to 500.000 deaths. Genetic changes in the influenza virus may lead to severe epidemics of global dimension (pandemics), such as the Spanish flu of 1918 that killed over 40 million people. Experts now fear another pandemic may arise shortly with unforeseeable consequences. Access to efficient drugs will be essential in such a catastrophic scenario. Again, the virus is likely to develop drug resistance.

EU research saves lives and money

The VIRGIL network will be able to rapidly and reliably determine resistance to new drugs and the drug susceptibility of emerging viral strains based on new treatments. The network aims to link up with the antiviral drug producing pharmaceutical industry in a cost-effective partnership that will help to ensure longer access to treatment and cure for the patients. This will help contain the socio-economic burden of viral resistance, now representing a major health problem with higher health care and drug development costs.

Fabio Fabbi | EU Commission
Further information:
http://www.europa.eu.int
http://www.virgil-net.org

More articles from Agricultural and Forestry Science:

nachricht New parsley virus discovered by Braunschweig researchers
17.05.2019 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

nachricht Franco-German research initiative on low-pesticide agriculture in Europe
16.05.2019 | Leibniz-Zentrum für Agrarlandschaftsforschung (ZALF) e.V.

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

Im Focus: A step towards probabilistic computing

Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future

When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...

Im Focus: Recording embryonic development

Scientists develop a molecular recording tool that enables in vivo lineage tracing of embryonic cells

The beginning of new life starts with a fascinating process: A single cell gives rise to progenitor cells that eventually differentiate into the three germ...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Summit charts a course to uncover the origins of genetic diseases

22.05.2019 | Life Sciences

New study finds distinct microbes living next to corals

22.05.2019 | Life Sciences

Stellar waltz with dramatic ending

22.05.2019 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>